UNSPSC 51373471: Hydrocodone/pheniramine/phenylephrine/phenylpropanolamine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373471 Hydrocodone/pheniramine/phenylephrine/phenylpropanolamine/pyrilamine (Commodity) does not align with actual recent state and local procurement activity under this code. The two recent opportunities posted under the code—a Seminole County, Florida naloxone and drug deactivation systems procurement and the Minnesota Multistate Cooperative Purchasing Alliance generic multi-source pharmaceuticals and OTC products RFP—involve naloxone, broad pharmaceutical inventories, and over-the-counter products, not the specific combination medication named in the code. The code's nominal scope does not reflect the buying patterns currently tagged to it in state and local systems.

Without opportunities specifically targeting the named combination drug, this code shows little actionable recent activity for vendors focused on the precise product formulation it describes. The mismatch between the code's specificity and the broader pharmaceutical procurement notices attached to it suggests either a cataloging inconsistency in the issuing agencies' systems or that this particular combination formulation is not actively solicited at the state and local level at present. Business development professionals tracking this code should verify whether opportunities in hand are genuinely relevant before responding, or monitor higher-tier pharmaceutical families for broader generic-drug and OTC product demand.